07.45 – 08.45:

Breakfast

Session III. LIPOPROTEINS AND LIPID TRANSPORT
Chaired by Ewa Ehrenborg (Sweden) and Jacob Juel Christensen (Norway)

08.45 – 09.10:

Cardiac lipids and their role for cardiomyocyte function
Malin Levin (Sweden)

09.10 – 09.15:

Discussion

09.15 – 09.30:

Fibroblast growth factor 21 potently reduces atherosclerosis and NASH development
Cong Liu (The Netherlands) - YIA

09.30 – 09.45:

Elevated remnant cholesterol and 2-fold mortality rates from cardiovascular and other causes, but not from cancer
Benjamin Nilsson Wadström (Denmark) - YIA

09.45 – 10.00:

Linking cellular lipid metabolism profiles to the outcomes of cholesterol-lowering therapy in a general population cohort study
Iryna Hlushchenko (Finland) - YIA

10.00 – 10.15:

Mapping the low-density lipoprotein interactome in mouse atherosclerosis
Rocio Muñiz (Spain)- YIA

10.15 – 11.15:

Poster Walk (Session III). Coffee in dining room.

11.15 – 11.40:

Perilipins and regulation of intracellular lipid droplets
Knut Tomas Dalen (Norway)

11.40 – 11.45:

Discussion

11.45 – 12.00:

Lipoprotein lipase expressed by vascular endothelial cells of activated thermogenic adipose tissues is dispensable for the processing of triglyceride-rich lipoproteins
Ellen Thiemann (Germany) - YIA

12.00 – 12.15

The role of hepatic melanocortin 1 receptor in the pathogenesis and therapeutics of metabolic disease
Keshav Thapa (Finland)

12.15 – 12.30

Impact of preeclampsia on umbilical cord blood lipid concentrations
Sofie Taageby Nielsen (Denmark)

12.30 – 12.45

Functional analysis of LDLR variants using automated systems
Mohammad Majharul Islam (Finland) - YIA

12.45 – 13.45

Lunch

Session IV. CARDIOVASCULAR DISEASE
Chaired by Anders Berg Wulff (Denmark) and Sander Kooijman (Netherlands)

13.45 – 14.10:

Cardiovascular disease prevention: from traditional risk scores to individualized prevention
Martin Bødtker Mortensen (Denmark)

14.10 – 14.15:

Discussion

14.15 – 14.30

Characterization of laminin isoforms in human atherosclerotic lesions and human vascular cells
Shuqi Xu (Denmark) - YIA

14.30 – 14.45

Pharmacological treatment with designer cytokine and exercise mimetic IC7Fc reduces atherosclerosis development  
Milena Schönke (The Netherlands) - YIA

14.45 – 15.00

Inhibition of pyruvate dehydrogenase kinase prevents abdominal aortic aneurysm formation in mice
Silke Griepke Dam Nielsen (Denmark) - YIA

15.00 – 15.15:

Endothelial integrity in intracranial atherosclerosis; the regulatory role of N6-methyladenosine (m6A) of the pro-atherogenic microRNA miR-494-3p in tight junction proteins
Tamar Woudenberg (The Netherlands) - YIA

15.15 – 16.00:

Poster Walk (Session IV). Coffee in dining room.

16.00 – 16.25:

Metabolic control of macrophages in atherosclerosis
Jan van den Bossche (The Netherlands)

16.25 – 16.30:

Discussion

16.30 – 16.45:

Genetic deficiency of indoleamine 2,3-dioxygenase (IDO)-1 aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
Aastna Arora (Denmark) - YIA

16.45 – 17.00:

Atherosclerotic Plaque Progression is Associated with Increased Collagen Carbamylation: Impact on Macrophage Functioning
Valeria Saar-Kovrov (The Netherlands) - YIA

17.00 – 17.15

Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons
Michael Davies (Denmark)

17.15 – 17.20

Concluding remarks
Mette Christoffersen (Denmark)

17.20 – 18.30:

Leisure time

18.30 – 19.00:

Cocktail

19.00 –

Banquet and dancing